Fed. Circ. Unwinds Ineligibility Ruling For Gene Therapy IP
By Theresa Schliep · February 20, 2026, 6:48 PM EST
The Federal Circuit on Friday saved Regenxbio and the University of Pennsylvania's gene therapy patent, finding that splicing together genes from different organisms results in a molecule that is "markedly different...
To view the full article, register now.